Product Name:(S)-22-(tert-Butoxycarbonyl)-45,45-dimethyl-10,19,24,43-tetraoxo-3,6,12,15,44-pentaoxa-9,18,23-triazahexatetracontanoic acid

IUPAC Name:2-(2-{2-[2-(2-{2-[(4S)-5-(tert-butoxy)-4-[20-(tert-butoxy)-20-oxoicosanamido]-5-oxopentanamido]ethoxy}ethoxy)acetamido]ethoxy}ethoxy)acetic acid

CAS:1188328-37-1
Molecular Formula:C45H83N3O13
Purity:99% HPLC
Catalog Number:CM1075330
Molecular Weight:874.17

Packing Unit Available Stock Price($) Quantity

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1188328-37-1
Molecular Formula:C45H83N3O13
Melting Point:-
Smiles Code:CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(O)=O)C(=O)OC(C)(C)C
Density:
Catalog Number:CM1075330
Molecular Weight:874.17
Boiling Point:
MDL No:
Storage:

Category Infos

Fatty Acid Modified Side Chains
Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.